All News

Found 5,966 articles

• Anesiva, Inc. Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy

  3/25/2008

• PLC Systems, Inc. Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.

  3/20/2008

• Aegera Therapeutics Initiates Phase 1 Clinical Trial of AEG33773

  3/18/2008

• Alexza Pharmaceuticals, Inc. Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status

  3/18/2008

• Auriga Laboratories, Inc. Announces FDA Approval of Liquadd(TM) Oral Solution for the Treatment of ADHD and Upcoming Product Launch

  3/10/2008

• Fralex Therapeutics Inc. Reaches 100th Patient Milestone in Fibromyalgia Study

  3/10/2008

• Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results

  3/7/2008

• Onset Therapeutics Announces Launch of Anestafoam(TM), a Novel Topical Anesthetic Foam

  3/6/2008

• Anika Therapeutics Reports Record Product Revenues for 2007

  3/6/2008

• Forest Laboratories, Inc. and Microbia, Inc. Announced Positive Results from Two Phase 2b Trials; Constipation Drug Meets Goal in Studies

  3/5/2008

• St. Charles Pharmaceuticals Novel Analgesic Gets Boost from National Institutes of Health (NIH)

  3/5/2008

• Alexza Pharmaceuticals, Inc.'s AZ-104 Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache

  3/3/2008

• Array BioPharma, Inc. Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial

  3/3/2008

• FDA Grants Priority Review for Eisai Company, Ltd.'s ACIPHEX(R) sNDA for Short-Term Treatment of GERD in Adolescents

  3/3/2008

• FDA Approves UCB Group and Sanofi-Aventis (France)'s XYZAL(R) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

  2/19/2008

• Applied Data Research Release: Emerging Targets and Therapeutic Approaches Driving Activity in Autoimmune Disease Therapeutics

  2/18/2008

• PLC Systems, Inc. Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline

  2/15/2008

• TorreyPines Therapeutics, Inc. to Reduce Work Force to Streamline Operations

  2/14/2008

• Cephalon, Inc. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting

  2/14/2008

• Multi Radiance Medical Release: World's First FDA-Cleared Combination Therapeutic Laser and TENS Unit Device Now Available to Help Chronic and Acute Pain Sufferers

  2/6/2008